We are live on
!
Find out more
FO
FT Options Portfolio holdings
AUM
$66.4M
1-Year Est. Return
18.48%
This Fund
S&P 500
This Quarter
Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$9.73M
(+8.4%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
177.31%
Top 10 Holdings %
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$3.82M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.47M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$2M |
| 4 |
Ulta Beauty
ULTA
|
+$1.86M |
| 5 |
MON
Monsanto Co
MON
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
+$7.18M |
| 2 |
Biogen
BIIB
|
+$4.33M |
| 3 |
Cal-Maine
CALM
|
+$3.64M |
| 4 |
Apple
AAPL
|
+$2.74M |
| 5 |
ALR
Alere Inc
ALR
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.95% |
| 2 | Consumer Staples | 5.72% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Technology | 3.35% |
| 5 | Materials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
CALL
Accenture
ACN
$87.9B
| $74K | 0.06% |
+8,900
| New | +$1.01M |
|
|
ITCI
177
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $73K | 0.06% |
+4,800
| New | +$194K |
|
178
CALL
Cigna
CI
$74.5B
| $72K | 0.06% |
25,700
-6,900
| -21% | -$901K |
|
179
PUT
Chipotle Mexican Grill
CMG
$44.2B
| $72K | 0.06% |
+250,000
| New | +$2.06M |
|
180
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $71K | 0.06% |
+85,000
| New | +$5.26M |
|
181
CALL
Rockwell Automation
ROK
$51.4B
| $70K | 0.06% |
+17,000
| New | +$1.99M |
|
182
CALL
Workday
WDAY
$35.8B
| $70K | 0.06% |
+8,400
| New | +$700K |
|
183
CALL
Kimberly-Clark
KMB
$36B
| $69K | 0.05% |
155,900
+21,400
| +16% | +$2.77M |
|
|
NVRO
184
CALL
DELISTED
NEVRO CORP.
NVRO
| $69K | 0.05% |
+10,000
| New | +$903K |
|
|
BLUE
185
CALL
DELISTED
bluebird bio
BLUE
| $68K | 0.05% |
2,957
+965
| +48% | +$699K |
|
|
RAD
186
CALL
DELISTED
Rite Aid Corporation
RAD
| $68K | 0.05% |
4,000
+2,500
| +167% | +$373K |
|
|
TWTR
187
PUT
DELISTED
Twitter, Inc.
TWTR
| $68K | 0.05% |
+30,000
| New | +$565K |
|
188
CALL
T-Mobile US
TMUS
$208B
| $67K | 0.05% |
+35,000
| New | +$1.61M |
|
|
MON
189
CALL
DELISTED
Monsanto Co
MON
| $67K | 0.05% |
46,200
+15,100
| +49% | +$1.58M |
|
190
CALL
Intel
INTC
$478B
| $65K | 0.05% |
30,400
-22,800
| -43% | -$807K |
|
191
CALL
Yelp
YELP
$1.44B
| $65K | 0.05% |
+21,000
| New | +$736K |
|
192
CALL
Nektar Therapeutics
NKTR
$2.31B
| $63K | 0.05% |
+3,333
| New | +$858K |
|
193
PUT
Walmart Inc
WMT
$909B
| $63K | 0.05% |
+224,400
| New | +$5.44M |
|
194
CALL
Target
TGT
$63.4B
| $61K | 0.05% |
85,000
+15,000
| +21% | +$1.08M |
|
195
PUT
AbbVie
ABBV
$450B
| $60K | 0.05% |
36,600
+20,000
| +120% | +$1.29M |
|
|
196
PUT
Kimberly-Clark
KMB
$36B
| $60K | 0.05% |
30,000
+27,500
| +1,100% | +$3.56M |
|
197
PUT
PTC Therapeutics
PTCT
$6.52B
| $59K | 0.05% |
+125,400
| New | +$1.02M |
|
198
AT&T
T
$152B
| $59K | 0.05% |
+1,928
| New | +$60.9K |
|
199
CALL
Gilead Sciences
GILD
$167B
| $57K | 0.05% |
137,700
+90,400
| +191% | +$7.34M |
|
|
SPLK
200
PUT
DELISTED
Splunk Inc
SPLK
| $57K | 0.05% |
18,100
-200
| -1% | -$12K |
|
Similar funds
MC
FIM
TLIC
MKCM
ACM
MFM
VE
GFWEV
FT Options's Q3 2016 Portfolio in Review
As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
FT Options deployed $224M of net new capital in Q3 2016, opening 153 new positions and adding to 113 existing holdings. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $2.74M trimmed.
- FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
- FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
- FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
- FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
- FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
- FT Options opened 153 new positions and closed 127 in Q3 2016.
- FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.
Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.